CPHI vs MCK · rev $4.1M vs P/E 20, rev $403.43B
China Pharma Holdings Inc (CPHI) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
CPHI currently screens at market cap $29.0M. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the CPHI and MCK stock pages for the full models.
Not investment advice.